Merck's Post-Vioxx comeback

merck_stock_chart

Merck instantly became the poster child for Big Pharma’s woes. The stock plunged 40 percent within a couple weeks. The company then suffered through a volatile 2005 — the year that Richard Clark succeeded Raymond Gilmartin as chief executive – before beginning its comeback last year.

Our girls are not guinea pigs

Is an upcoming mass inoculation of a generation unnecessary and potentially dangerous? MacLeans.ca CATHY GULLI¬† August 27, 2007 The morning after Emily Cunningham got a shot of Gardasil, the new vaccine that protects against four strains of the human papilloma virus(HPV)that can cause cervical cancer and genital warts, she woke up with a headache, and Continue Reading …